Kristen Barton

Kristen Barton is a managing director and co-director of investment research. Kristen is also a senior research analyst focusing on agriculture & biotech companies. Prior to joining Tech Insider in 2010, Barton worked in equity research at RBC Capital Markets in Minneapolis, MN and Edward Jones in St. Louis, Mo. She was recognized for her stock picking in the 2012 Wall Street Journal "Best on the Street" publication.

NYSE gainers: Weatherford International (NYSE:WFT), SouFun Holdings (NYSE:SFUN), Precision Drilling (NYSE:PDS), Oasis Petroleum Inc. (NYSE:OAS)

Staff at the Shannon Way-based oil rig manufacturer Weatherford International Ltd (NYSE:WFT) are downing tools to cycle 400 miles to the French capital in a bid to raise £10,000 for Prostate Cancer UK. Daryl Stroud is the company’s managing director and will join his team, which includes a worker based in the US who will…

Read More
FB Nasdaq FB Facebook

Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Johnson & Johnson (NYSE:JNJ)

A proxy advisory firm has asked shareholders of the Indian unit of Wyeth to oppose its merger deal with Pfizer Inc. (NYSE:PFE) as the share swap ratio is skewed in favour of Pfizer Inc. (NYSE:PFE). Shareholder Empowerment Services (SES) has made this suggestion ahead of the shareholder meeting this week. Pfizer Inc. (NYSE:PFE) stock performance…

Read More

Industrial Goods Losers: Real Goods Solar (NASDAQ:RGSE), Highpower International Inc (NASDAQ:HPJ), ExOne Co (NASDAQ:XONE), Vertex Energy (NASDAQ:VTNR)

Real Goods Solar, Inc. (NASDAQ:RGSE) following the announcement of investing in a solar provider located in Hawaii. Called as Elemental Energy this solar player is already an established brand – Sunetric- in delivering a range of services as installation. Real Goods Solar, Inc. (NASDAQ:RGSE) will hold over $9 million of the stock and has offered…

Read More
Gilead Sciences GILD NASDAQ:GILD

Biotech Losers: MannKind Corporation (NASDAQ:MNKD), Rexahn Pharmaceuticals (NYSEMKT:RNN), ZIOPHARM Oncology (NASDAQ:ZIOP), Seattle Genetics (NASDAQ:SGEN)

MannKind Corporation (NASDAQ:MNKD) announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for AFREZZA(R) by three months to July 15, 2014 in order to provide time for a full review of information submitted by MannKind in response to the FDA’s requests.MannKind Corporation (NASDAQ:MNKD) stock performance…

Read More

Trader’s Alert: Yahoo! Inc. (NASDAQ:YHOO), Sprint Corporation (NYSE:S), Vodafone Group (NASDAQ:VOD), Amazon.com, Inc. (NASDAQ:AMZN)

Yahoo Inc. (NASDAQ:YHOO) and Google are among the most prominent Internet services to say they have already insulated most of the most popular services from Heartbleed. At Yahoo Inc (NASDAQ:YHOO), the repairs have been made on a list of services that includes its home page, search engine, email, finance and sport sections, Flickr photo-sharing service…

Read More

Consumer Goods Active Runners: General Motors (NYSE:GM), Ford Motor Company (NYSE:F), The Coca-Cola (NYSE:KO), Apple Inc. (NASDAQ:AAPL)

General Motors Company (NYSE:GM) is under fire for missing a deadline last week to answer 107 questions requested by the NHTSA in its investigation. On Wednesday, the agency announced it was fining the automaker $7,000 for every day it fails to comply. General Motors Company (NYSE:GM) stock performance was -0.95% in last session and finished…

Read More